Elevance Health, Inc. · NYSE:ELV
Kaye Mark sold 10,584 Elevance Health, Inc. shares (Form 4)
Traded Oct 22, 2026 · Filed Oct 23, 2026
On Oct 22, 2026, Kaye Mark (EVP & CFO) sold 10,584 Elevance Health, Inc. shares at an average US$440.13 for US$4.66M, leaving 19,919 shares. Filed Oct 23, 2026 (Form 4).
- Sold
- 10,584 shares
- Price
- US$440.13 average (US$434.00 to US$447.19)
- Value
- US$4.66M
- Holding after
- 19,919 shares
- Trading plan
- No
- Role
- EVP & CFO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 22, 2026 | Common Stock | Sale | 400 | US$434.00 | 30,103 | Direct |
| Oct 22, 2026 | Common Stock | Sale | 321 | US$435.25 | 29,782 | Direct |
| Oct 22, 2026 | Common Stock | Sale | 1,660 | US$436.20 | 28,122 | Direct |
| Oct 22, 2026 | Common Stock | Sale | 560 | US$437.07 | 27,562 | Direct |
| Oct 22, 2026 | Common Stock | Sale | 240 | US$438.22 | 27,322 | Direct |
| Oct 22, 2026 | Common Stock | Sale | 1,160 | US$439.25 | 26,162 | Direct |
| Oct 22, 2026 | Common Stock | Sale | 1,720 | US$440.44 | 24,442 | Direct |
| Oct 22, 2026 | Common Stock | Sale | 2,343 | US$441.34 | 22,099 | Direct |
| Oct 22, 2026 | Common Stock | Sale | 480 | US$442.61 | 21,619 | Direct |
| Oct 22, 2026 | Common Stock | Sale | 440 | US$443.81 | 21,179 | Direct |
| Oct 22, 2026 | Common Stock | Sale | 160 | US$444.85 | 21,019 | Direct |
| Oct 22, 2026 | Common Stock | Sale | 827 | US$446.05 | 20,192 | Direct |
| Oct 22, 2026 | Common Stock | Sale | 273 | US$447.19 | 19,919 | Direct |
Source
Download original · View original at SEC